Predictive factor for the response to adjuvant therapy with emphasis in breast cancer Journal Article


Authors: Munster, P. N.; Norton, L.
Article Title: Predictive factor for the response to adjuvant therapy with emphasis in breast cancer
Abstract: One of the major challenges of early-stage breast cancer is to select the adjuvant therapy that ensures the most benefits and the least harm for the patient. The definition of accurate predictive factors is therefore of paramount importance. So far the choice of adjuvant therapy has been based on the number of affected lymph nodes and the hormone receptor status of the patient. This paper evaluates the use of other tumor-related markers as predictive factors for adjuvant therapy. These include HER2, p53 and Bcl-2, cathepsin B, p27, proliferating cell nuclear antigen (PCNA), cyclin D, Ki-67, and vascular endothelial growth factor (VEGF).
Keywords: vasculotropin; cancer survival; controlled study; doxorubicin; fluorouracil; risk benefit analysis; adjuvant therapy; cancer adjuvant therapy; chemotherapy, adjuvant; methotrexate; cancer diagnosis; diagnostic accuracy; genetic analysis; ki 67 antigen; protein analysis; protein bcl 2; unindexed drug; vasculotropin receptor; breast cancer; antineoplastic combined chemotherapy protocols; tumor markers, biological; cyclophosphamide; melphalan; protein interaction; chemosensitivity; vasculotropin inhibitor; breast neoplasms; protein p53; tumor marker; monoclonal antibody; molecular marker; tumor suppressor gene; early cancer; gene interaction; lymph node; protein p27; drug response; tyrosine kinase receptor; predictive value of tests; tumor suppressor protein p53; epirubicin; receptor, erbb-2; cathepsin b; taxane derivative; cycline; estrogen receptor; progesterone receptor; trastuzumab; anthracycline; hormone receptor; cyclin d1; proto-oncogene proteins c-bcl-2; oncogene neu; predictive factors; drug choice; cytochrome c; dimer; apoptotic protease activating factor 1; humans; prognosis; human; female; article; oncogene c erb
Journal Title: Breast Cancer Research
Volume: 3
Issue: 6
ISSN: 1465-5411
Publisher: Biomed Central Ltd  
Date Published: 2001-10-01
Start Page: 361
End Page: 364
Language: English
DOI: 10.1186/bcr323
PUBMED: 11737886
PROVIDER: scopus
PMCID: PMC138701
DOI/URL:
Notes: Export Date: 21 May 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Larry Norton
    758 Norton